GPBAR1 and Insulin resistance: In murine models, 6α-hydroxylated bile acids improve glucose metabolism and body weight via TGR5; observational data suggest links between altered hydroxylated bile acid profiles, insulin resistance and cardiometabolic risk; potential indirect effects on CNS through improved metabolic control and reduced inflammation.